Pfizer Raises 2026 Forecasts on Third-Quarter Results
Pfizer said Eliquis and cancer drugs drove its third-quarter results. The headline reports higher 2026 forecasts but provides no figures.
Related stories
Groupe BPCE Q3 Net Income Rises 25% to €1.4B
Groupe BPCE reported Q3-26 net banking income of €7.0B, up 9% year over year. Nine-month net income was €3.8B, up 28%.
M impact | EARNINGS | Nov 03, 2026, 04:52 PM UTC
Yum! Brands Beats Third-Quarter Profit Views
Yum! Brands' third-quarter profit beat Wall Street views.
M impact | EARNINGS | Nov 03, 2026, 04:52 PM UTC
NOS Reports Q3 EBITDA of EUR 225.6 Million
M impact | EARNINGS | Nov 03, 2026, 04:47 PM UTC
Viridien Reports $35M Net Cash Flow in Q3
M impact | EARNINGS | Nov 03, 2026, 04:47 PM UTC
Viridien Reports Q3 Operating Income of USD 13 Million
M impact | EARNINGS | Nov 03, 2026, 04:45 PM UTC
Viridien Reports Q3 Net Income of USD -10 Million
L impact | EARNINGS | Nov 03, 2026, 04:45 PM UTC